GGrantIndex
← Leaderboards

David R Boulware

University Of Minnesota

Google Scholar ↗PubMed ↗ORCID ↗
$24,302,588
Attributed
$34,154,874
Total exposure
14
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.8M · FY2009–25
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$34,154,874 · 14

By mechanism

R01$16,392,525 · 4
U01$10,974,088 · 2
T32$2,709,541 · 1
UG3$2,145,116 · 1
K23$530,496 · 1
D43$498,800 · 1

Top collaborators

Others in their field

Top investigators on “Persons”

Research focus

PersonsAcquired Immunodeficiency SyndromeAfrica South Of The SaharaCessation Of LifeCryptococcal MeningitisUgandaAntiretroviral TherapyMeningitisInfectionAfricaDiagnosisCryptococcusMortalityCaringIncidenceHiv TherapyProspectiveAdultCohortClinical ResearchEnrollmentResourcesAttributable MortalityMorbidity - Disease Rate

Grant awards (61)

TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies$645,211
R01 · FY2025 · AI · contact PI
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis$332,546
R01 · FY2025 · NS · contact PI
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis$297,733
R01 · FY2025 · NS · contact PI
Minnesota-Makerere-Mbarara Neuro-Infectious Disease Research Training Consortium$248,400
D43 · FY2025 · TW · contact PI
Midcareer Mentoring for Clinical Research in HIV/AIDS-related cryptococcal and TB meningitis$215,860
K24 · FY2025 · AI · contact PI
TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies$649,938
R01 · FY2024 · AI · contact PI
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis$644,029
R01 · FY2024 · NS · contact PI
Infectious Disease Training in Clinical Investigation$370,389
T32 · FY2024 · AI · contact PI
Minnesota-Makerere-Mbarara Neuro-Infectious Disease Research Training Consortium$250,400
D43 · FY2024 · TW · contact PI
Midcareer Mentoring for Clinical Research in HIV/AIDS-related cryptococcal and TB meningitis$215,860
K24 · FY2024 · AI · contact PI
Encochleated Oral Amphotericin for HIV-related Cryptococcal Meningitis Trial: Phase 3 Trial$2,145,116
UG3 · FY2023 · NS · contact PI
TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies$660,699
R01 · FY2023 · AI · contact PI
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis$620,692
R01 · FY2023 · NS · contact PI
Infectious Disease Training in Clinical Investigation$341,881
T32 · FY2023 · AI · contact PI
TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies$670,820
R01 · FY2022 · AI · contact PI
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis$626,250
R01 · FY2022 · NS · contact PI
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial$625,976
R01 · FY2022 · NS · contact PI
Infectious Disease Training in Clinical Investigation$285,506
T32 · FY2022 · AI · contact PI
11th International Conference on Cryptococcus and Cryptococcosis (ICCC)$17,000
R13 · FY2022 · AI · contact PI
TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies$696,169
R01 · FY2021 · AI · contact PI
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis$632,702
R01 · FY2021 · NS · contact PI
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial$632,233
R01 · FY2021 · NS · contact PI
Infectious Disease Training in Clinical Investigation$259,691
T32 · FY2021 · AI · contact PI
Cryptococcal Antigen Screening plus Sertraline (C-ASSERT)$670,413
U01 · FY2020 · AI · contact PI
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis$638,208
R01 · FY2020 · NS · contact PI
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial$637,925
R01 · FY2020 · NS · contact PI
Phased Implementation of a Public Health Programme: Cryptococcal Screening and Treatment in South Africa$564,586
R01 · FY2020 · AI · contact PI
Infectious Disease Training in Clinical Investigation$344,233
T32 · FY2020 · AI · contact PI
Cryptococcal Antigen Screening plus Sertraline (C-ASSERT)$129,417
U01 · FY2020 · AI · contact PI
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis$654,844
R01 · FY2019 · NS · contact PI
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial$654,844
R01 · FY2019 · NS · contact PI
Cryptococcal Antigen Screening plus Sertraline (C-ASSERT)$649,661
U01 · FY2019 · AI · contact PI
Phased Implementation of a Public Health Programme: Cryptococcal Screening and Treatment in South Africa$564,174
R01 · FY2019 · AI · contact PI
Infectious Disease Training in Clinical Investigation$300,005
T32 · FY2019 · AI · contact PI
Cryptococcal Antigen Screening plus Sertraline (C-ASSERT)$116,551
U01 · FY2019 · AI · contact PI
Phased Implementation of a Public Health Programme: Cryptococcal Screening and Treatment in South Africa$573,846
R01 · FY2018 · AI · contact PI
Cryptococcal Antigen Screening plus Sertraline (C-ASSERT)$508,514
U01 · FY2018 · AI · contact PI
Infectious Disease Training in Clinical Investigation$272,444
T32 · FY2018 · AI · contact PI
Cryptococcal Antigen Screening plus Sertraline (C-ASSERT)$646,880
U01 · FY2017 · AI · contact PI
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis$636,646
R01 · FY2017 · NS · contact PI
Phased Implementation of a Public Health Programme: Cryptococcal Screening and Treatment in South Africa$578,190
R01 · FY2017 · AI · contact PI
Infectious Disease Training in Clinical Investigation$324,942
T32 · FY2017 · AI · contact PI
Operational Research for Cryptococcal Antigen Screening (ORCAS) of HIV Patients$657,893
U01 · FY2016 · AI · contact PI
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis$636,646
R01 · FY2016 · NS · contact PI
Phased Implementation of a Public Health Programme: Cryptococcal Screening and Treatment in South Africa$601,458
R01 · FY2016 · AI · contact PI
Infectious Disease Training in Clinical Investigation$210,450
T32 · FY2016 · AI · contact PI
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis$636,646
R01 · FY2015 · NS · contact PI
Trial for the Optimal Timing of HIV Therapy after Cryptococcal Meningitis$1,301,044
U01 · FY2014 · AI · contact PI
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis$630,279
R01 · FY2014 · NS · contact PI
Trial for the Optimal Timing of HIV Therapy after Cryptococcal Meningitis$1,395,274
U01 · FY2013 · AI · contact PI
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis$649,235
R01 · FY2013 · NS · contact PI
Trial for the Optimal Timing of HIV Therapy after Cryptococcal Meningitis$1,484,331
U01 · FY2012 · AI · contact PI
Immune Reconstitution Syndrome in HIV infected Persons in Resource-Limited Areas$132,624
K23 · FY2012 · AI · contact PI
Trial for the Optimal Timing of HIV Therapy after Cryptococcal Meningitis$1,722,067
U01 · FY2011 · AI · contact PI
Immune Reconstitution Syndrome in HIV infected Persons in Resource-Limited Areas$132,624
K23 · FY2011 · AI · contact PI
Impact of HIV and HIV therapy on the Etiology and Outcome of Meningitis in Uganda$130,091
R21 · FY2011 · NS · contact PI
Trial for the Optimal Timing of HIV Therapy after Cryptococcal Meningitis$1,692,043
U01 · FY2010 · AI · contact PI
Impact of HIV and HIV therapy on the Etiology and Outcome of Meningitis in Uganda$145,497
R21 · FY2010 · NS · contact PI
Immune Reconstitution Syndrome in HIV infected Persons in Resource-Limited Areas$132,624
K23 · FY2010 · AI · contact PI
Trial for the Optimal Timing of HIV Therapy after Cryptococcal Meningitis$180,000
R34 · FY2009 · AI · contact PI
Immune Reconstitution Syndrome in HIV infected Persons in Resource-Limited Areas$132,624
K23 · FY2009 · AI · contact PI